Related Experiment Video
Updated: Sep 23, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Immunopathogenesis of HIV-related heart muscle disease: current perspectives
Peter F Currie1, Nicholas A Boon
1Perth Royal Infirmary, Perth, UK.
Insights
As HIV survival improves, heart muscle disease (cardiomyopathy) is a growing concern. This review explores the complex causes of HIV-associated cardiomyopathy, a serious condition affecting HIV patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Antiretroviral therapies enhance survival for HIV patients.
- Increased survival leads to higher risk of end-organ damage, including heart muscle disease.
- HIV-associated cardiomyopathy is a significant cardiovascular complication with a poor prognosis.
Purpose of the Study:
- To examine the immunopathogenesis of HIV-associated cardiomyopathy.
- To understand the complex and multifactorial causes of heart muscle disease in HIV patients.
Main Methods:
- Literature review of current understanding.
- Analysis of immunopathogenesis mechanisms.
Main Results:
- HIV-associated cardiomyopathy presents as dilated cardiomyopathy or ventricular dysfunction.
- It affects up to 5% of HIV patients, leading to heart failure.
- The exact cause is complex and multifactorial, involving immune system pathways.
Conclusions:
- HIV-associated cardiomyopathy is an emerging and serious complication.
- Understanding its immunopathogenesis is crucial for patient outcomes.
- Further research is needed to clarify the multifactorial causes.
Abstract:
As more effective antiretroviral therapies improve survival times, growing numbers of HIV-positive patients are at risk of developing end-organ damage or neoplasia. Heart muscle disease is the most important cardiovascular manifestation of HIV infection and seems set to become increasingly prevalent. This may take the form of either a dilated cardiomyopathy or isolated left or right ventricular dysfunction, is associated with a poor prognosis, and results in symptomatic heart failure in up to 5% of HIV patients. The precise cause of HIV-associated cardiomyopathy remains unclear but is undoubtedly complex, and most probably multifactorial. This report examines our current understanding of the immunopathogenesis of HIV-associated cardiomyopathy.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Heart Failure II: Pathophysiology
Rheumatic Heart Disease I: Introduction
Pathophysiology of Heart Failure
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...